Medios AG

ILM1

Equity

ISIN DE000A1MMCC8 / Valor 19069483

Xetra (2024-11-20)

EUR 13.84%

Medios AG
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Medios AG is an innovative specialty pharmaceuticals company that specializes in patient-specific medicinal products. The company focuses on providing integrated solutions and partnership intelligence to ensure optimal supply of these products. Medios AG's business model revolves around meeting the growing demand for personalized medicine in the healthcare industry.

Summarized from source with an LLMView SourceSector: Healthcare

Revenue Growth

In the second quarter of 2019, Medios AG achieved a significant milestone by surpassing the half-billion Euro revenue mark for the first time. The company's revenue grew dynamically, with a 58% increase compared to the previous year, reaching 517 million Euros.

EBITDA Increase

Medios AG reported a substantial increase in its EBITDA for Q2 2019. The EBITDA, before special effects, rose by 51%, reflecting the company's strong operational performance and efficient cost management strategies.

EBT Improvement

The earnings before taxes (EBT) for Medios AG in Q2 2019 also saw a significant rise. The EBT, adjusted for special effects, increased by 48%, demonstrating the company's ability to enhance profitability alongside revenue growth.

Stock Performance

Medios AG's stock nearly doubled in value over the course of 2019. The stock price saw an impressive increase of almost 96%, significantly outperforming the broader German stock market and reflecting investor confidence in the company's growth trajectory.

Strategic Acquisitions

In March 2020, Medios AG acquired Kölsche Blister GmbH, a company specializing in patient-specific blister packaging. This acquisition aligns with Medios AG's strategy to expand its value chain in the Specialty Pharma sector and tap into new growth markets.

Summarized from source with an LLMView Source

Key figures

-20.0%1Y

-63.2%3Y

-40.3%5Y

Performance

40.3%1Y

39.4%3Y

41.6%5Y

Volatility